Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Based in Aliso Viejo, California, RxSight specializes in ophthalmic devices and continues to be an active player in the medical technology sector. The company maintains a strong balance sheet with more cash than debt, positioning it well for future growth opportunities. The company maintains a strong balance sheet with more cash than debt, positioning it well for future growth opportunities.
Based in Aliso Viejo, California, RxSight specializes in ophthalmic devices and continues to be an active player in the medical technology sector. The company maintains a strong balance sheet with more cash than debt, positioning it well for future growth opportunities.
Based in Aliso Viejo, California, RxSight specializes in ophthalmic devices and continues to be an active player in the medical technology sector.
In other recent news, RxSight Inc. It has been the subject of several recent analyst corrections. Stifel lowered its rating on the company’s stock and cut its price target due to concerns about competition and international expansion efforts. The company’s decision reviewed RxSight’s Q4 2024 preliminary results, which reported total revenue of $40.2 million, in line with both Stifel and consensus estimates.
In contrast, Needham & Company maintained a positive stance on RxSight and reiterated a Buy rating. The company’s 2025 revenue forecast beat consensus estimates, estimating revenue between $185 million and $197 million. However, Stifel et al Wells Fargo (NYSE: ) Slowing adoption forecasts and limited growth potential, respectively, have dragged down RxSight’s stock.
UBS initiated RxSight with a Buy rating, highlighting the company’s strong position and projected sales growth of more than 20% through 2028.
This article was created by AI Support and reviewed by an editor. See our T&C for more information.
